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1. Your mother and your uncle were physicians. Was it almost inevitable for you to enter medicine, 
or did you have other interests as well? 
Who knows why somebody decides to study medicine. I recently read somewhere that the majority 
of physicians in the USA decided on a medical career due to the feeling of power and status associ-
ated with it. I doubt that that was a motive for many in our time or now in Croatia. It is true that my 
family was rather medically oriented and I heard many interesting medical stories at the dinner table. 
I also read several classics that influence people to pick up medical studies like Eleven Blue Men and 
Microbe Hunters, also others, not so common, such as Not as a Stranger and Arrowsmith. However I 
was much more impressed by books like Gamow’s One Two Three….Infinity and seriously considered 
studying mathematics. However, I soon realized that, although I could handle high school mathemat-
ics with ease, I was certainly not born with a “real feel” for mathematics. It seemed to me there is very 
little purpose in being an “average” mathematician, while, with proper application one could become a 
good physician. You have to realize how difficult is to remember the mental state and decision-making 
process of a teenager sixty years later, but it seems to me that my decision was made on the basis of a 
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Figure 1. Annual Meeting of Yugoslav Medical Students in Rijeka 1964. From left to right: Pavao Rudan, Ivan Damjanov, Ana Jo, 
Vlatko Grnja, Davor Solter, Jasenka Pravdić, Jaroslav Soudyl, Nada Dabić
Essay - Interviews
RAD 547. Medical Sciences 54-55 (2021) : 138-147                   www.rad-med.com 139 June 2021   -   Vol 547 = 54-55
2. Any fond memories of your medical school days?
Once there I liked to go to the lectures and missed very few 
during five years of study. Not so much because I believed I 
could learn something better this way instead of reading it in a 
textbook, but I liked to see how different people presented their 
subject and knowledge. In one aspect my medical studies were 
somewhat unusual and were more like medical studies must 
have been long ago, when a young apprentice was attached to a 
physician and learned by watching and doing. Since my mother 
and uncle were, respectively, a senior and respected internist and 
a surgeon, I was able to profit from this close association. After 
the first year I spent every summer working in my mother’s ward 
at Vinogradska Hospital and every Saturday and Saturday night 
in the Traumatology Hospital. As you can imagine after the first 
year of medical school, I did not know anything so in the begin-
ning I just followed people around and listened and did simple 
chores. As the time progressed I did more and more, so after five 
years I had a lot of practical experience in dealing with patients, 
something which was very useful when I had to be an independ-
ent physician during my army service.
3. After two years of medicine you became a teaching assis-
tant in Anatomy, spending for the next three years most of 
your afternoons dissecting cadavers and teaching medical 
students classical anatomy. What did you learn from this 
teaching stint?
Indeed, after my second year of medical school I did became a 
student assistant (demonstrator) in the Anatomy Department 
and a year later, a teaching assistant guiding and examining stu-
dents during dissection. Anatomy class is the first tone in which 
medical students do something “medical” and they are usually 
quite interested. We also tried to make anatomy more relevant by 
indicating how important an anatomical fact could be in under-
standing and treating specific diseases. It is also the first class in 
which medical students realize how much memorization of facts 
is important in medicine. It is true that you can always look it 
up, but it would be a poor surgeon who would stop in the mid-
dle of an operation to consult an anatomy textbook. This period 
was important to me as I learned how to teach, I started doing 
research I also wrote my first research paper. One could say that, 
unknowingly, I started to choose my future career.
Figure 2. The Wistar Institute 1983. The Honorable Richard S. Schweiker, U.S. Secretary of Health and Human Services visited Solter’s 
laboratory to hear about nuclear transfer and imprinting. From left to right: Hilary Koprowski, Richard S Schweiker, NN, Davor Solter
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4. After graduation did you have clear plans for your profes-
sional development? 
I don’t think so. It seems to me now that what happened to 
me after medical school and my one year of army service was a 
mixture of vague planning and serendipity. I only knew that I 
didn’t want to become a clinician. (my family blamed this on the 
amount of time I spent working with patients during medical 
school). So, I decided to specialize in pathology and started to 
work in the Pathology Department in the Vinogradska Hospital. 
Fate intervened and after several events too boring to recapitulate 
I ended up two years later as an Assistant Professor back at the 
Anatomy Department, and more or less decided on an academic 
research career.
5. You ended up working in the Department of Biology under 
professor Nikola Skreb. How important was Nikola Skreb 
for you and your future scientific career?
While working in the Anatomy Department I started postgradu-
ate studies (the MS degree was conditional for PhD studies) 
at the Faculty of Arts and Sciences at the Zagreb University . I 
did not wish to choose an anatomical subject so my friend, and 
current interviewer, suggested I ask Professor Nikola Skreb in 
Department of Biology if I could work there studying mam-
malian development, a subject I knew nothing about. Professor 
Skreb said yes and that was that. I certainly did not know at that 
time that my life work had been decided. I moved to the Biology 
Department, finished my PhD and started planning to go abroad 
for postdoctoral work. Nikola Skreb was a wonderful men-
tor, able to adjust his approach to the needs and abilities of his 
mentees. In my case, Nikola suggested a subject for my Master’s 
degree research project, which took me six months to figure out 
that it would not work; but by that time I read enough to come 
with an alternative theme which he approved. Early mammalian 
development was a perfect subject for our conditions in Zageb at 
this time. Not much work had been done on this subject in the 
global scientific community and several months of reading were 
sufficient to cover the whole field (today one would never be able 
to catch up with the published papers in the field; they are now 
coming faster than one can read). In addition, quite a lot could 
be done with very simple and readily available techniques. 
6. How did you enter the international scene?
During the four years I spent at the Biology Department I col-
laborated with my friend Ivan Damjanov, in the Department 
of Pathology. We both worked for our PhDs together and split 
our collaborative results into two themes. One of the interest-
ing and unexpected results was the finding that if one transfers a 
gastrulating mouse embryo under the kidney capsule of another 
mouse, it will develop into a tumor containing mature tissues, a 
teratoma (which had been described before) but also containing 
undifferentiated malignant cells, a teratocarcinoma. Finding that 
the mouse embryo contains undifferentiated cells, which during 
normal development differentiate into adult tissues, but that can 
also persist in the undifferentiated state forever and give rise to 
malignant tumor, was novel enough to publish in Nature (1). 
This and other papers published in international journals estab-
lished both Ivan and me as researchers in the field of mammalian 
development and embryonic stem cells.
7. You moved to Wistar Institute, affiliated with the Universi-
ty of Pennsylvania, Philadelphia in 1973, and worked there 
for almost 20 years. Why did you choose that institute?
Going abroad for postdoctoral studies was always a rite of pas-
sage and in my opinion an essential part of the education of a 
scientist. I applied to three different laboratories in USA and 
received an encouraging response from the Wistar Institute in 
Philadelphia. Director, Hilary Koprowski, asked me to apply for 
a Damon Runyon Cancer Foundation Fellowship which I did 
and was lucky enough to receive, so in January of 1973 I started 
working at The Wistar Institute. I was planning to stay there 
two, maybe three years, little did I know that I will spend next 
eighteen years in Philadelphia. The funny part was that I went 
there expecting to find a great place to learn mammalian devel-
opment, but they accepted me because they needed somebody 
who could work with mammalian embryos. In the end one of us 
was right.
8. At that time the Head of the Wistar Institute was Hilary 
Koprowski, an internationally known virologist and im-
munologist . How much did he help you establish yourself 
as an independent scientist? 
Hilary Koprowski was a great scientist and an excellent institute 
Director who had turned the Wistar Institute from rather a 
sleepy place into a leading scientific center. In the beginning he 
was rather interested in my work, but then other subjects drew 
his attention, and I was left to proceed on my own. The greatest 
advantage of being there was the quality of the scientists which 
Hilary managed to recruit was excellent and most of them were 
collegial and willing to collaborate and help. The diversity of 
interest was such that it was very likely that any technical or sci-
entific problem one had, could be answered, or at least discussed 
by another researcher next door or one floor away.
9. At Wistar you met Barbara B. Knowles. Very soon thereaf-
ter you started collaborating with her and her name began 
appearing on some of your most important papers. There 
is a saying: Behind a successful man there is often an even 
more successful woman. Was Barbara that woman in your 
life?
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Figure 3. The Congress in Dubrovnik 1986. From left to right: Draško Šerman, Ivan Damjanov, Nikola Škreb, Davor Soloter, Anton Švajger
Barbara was also part of the loosely structured Koprowski group. 
When I arrived, she was working on somatic cell hybrids and 
immunology. Wistar was undergoing major construction and the 
animal colony was moved into an old building rented from the 
University of Pennsylvania a couple of miles from The Wistar 
Institute. Barbara and I, and several other scientists working with 
mice moved there. Barbara and I each had a small group so we 
decided to join forces and avoid duplication of facilities in the 
small quarters assigned to us. This led to work on joint projects 
and the most successful and enduring collaboration of my life. 
Barbara is a much more serious and studious scientist than I 
and she taught me how to be very critical and suspicious of easy 
explanations and incomplete data. Since that time, we lived 
and worked together, although we always had both joint and 
individual projects and students and postdoctoral fellows. So, the 
short answer is yes.
10. After twenty years at Wistar you moved to the Max Planck 
Institute in Freiburg, Germany. Why? Was it easy?
It was time for me to move on, but this led to a quest to find 
the right place. At a small, excellent research institute like the 
Wistar you either had to grow or die. Wistar was not a very well-
endowed institute and everything, including your salary, came 
from the grant money that you raised to support yourself. By 
early nineties Barbara’s and my labs were operating with a yearly 
budget of close to two million dollars and I had the impression 
that I was doing nothing but writing grant applications, progress 
and final reports. Also, I was involved in the NIH grant ma-
chinery, evaluating grant and program projects in various Study 
Sections and Councils. It became a struggle to find time to go 
to the lab and do some work. Just at that time my friend and 
colleague, Rolf Kemler, came up with the suggestion that I come 
to the Max-Planck Institute of Immunbiology in Freiburg. This 
Institute was initially devoted to immunology but Rolf came 
there to work on embryonic stem cells and mammalian develop-
mental biology and he needed a colleague with similar interests. 
It seemed like an ideal solution, stable, no grant writing and I 
could help young scientists develop into independent research-
ers. A year later Barbara left Wistar to become the Director for 
Research at The Jackson Laboratory in Bar Harbor. She was very 
busy with organizational problems and with many projects she 
initiated but we continued a transatlantic life and collaboration, 
mostly on the molecular biology of early mouse development. It 
was pioneering and technically very demanding work and I think 
we did very well in identifying the scope of the preimplantation 
mouse embryo transcriptome and in characterizing several devel-
opmentally important genes.
Essay - Interviews
RAD 547. Medical Sciences 54-55 (2021) : 138-147                   www.rad-med.com 142 June 2021   -   Vol 547 = 54-55
11. Following your retirement from Germany, you spent a few 
years in Singapore and then some time in Bangkok. How 
do these experiences compare with your years in Philadel-
phia and Freiburg? 
Barbara and I retired more or less at the same time, debating 
what to do next, when the opportunity arose to join the newly 
established Institute of Medical Biology (IMB) at A*STAR, in 
Singapore. A*STAR was and is a very ambitious project started 
by the Singapore Government to establish the scientific base 
upon which to build the new economy of Singapore. Singapore 
was quite good in physical and chemical sciences but needed to 
develop breadth and depth in biology and biomedicine. To do 
so they established a massive conglomerate of several independ-
ent research institutes and imported scientists from all over the 
world to establish the necessary science. When we joined IMB 
our duties/tasks were to do the best possible research, to publish 
in the most prominent journals and to train young Singaporean 
scientists. The five years we spent there were in a way returning 
to our early days at Wistar when we were most productive and 
effective. Barbara and I never stopped working at the bench but 
other duties at the Max-Plank Institute and at The Jackson Labo-
ratory often interfered. In Singapore we had no other duties, we 
assembled a small group of postdoctoral fellows from Singapore 
and other countries, and we made it clear that the lab would 
close in five years, so we had better get going. With everybody 
working on their individual but interconnected projects we were 
quite efficient and published several breakthrough papers in Sci-
ence (2, 3) and many more in other high-quality journals. Even 
more importantly we succeeded in getting every postdoctoral 
fellow well established, published and successfully employed. I 
think we were very lucky to finish our career in such a place and 
in such a manner.
12. During your long scientific career, you made quite a few 
important observations and discoveries. What are your 
three most important contributions to science?
It is interesting that each of my “important” contributions were 
a combination of technical development which made subsequent 
discoveries possible. In the late seventies we worked on the role 
of cell surface molecules in early mammalian development. This 
was at the time when hybridoma technology was just being 
developed and we were able to adapt this technology to preim-
plantation mouse embryos. Working with these early mouse 
embryonic stages the issue of quantity is always crucial. One can 
easily immunize with millions and millions of cells but collecting 
even a thousand embryos is always a problem. Nevertheless, we 
were able to collect sufficient numbers of embryos, use them as 
immunogen and produce and characterize several monoclonal 
Figure 4. New Orleans 1998. Davor Solter receives March of Dimes Prize in Developmental Biology. Anna Eleanor Roosevelt, 
granddaughter of March of Dimes founder President Franklin Delano Roosevelt, Davor Solter, Barbara B. Knowles
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antibodies reactive with stage specific antigens on the surface 
of preimplantation mouse embryos (4, 5). Interestingly these 
reagents also proved crucial in isolating and establishing lines 
of human embryonic stem cells. We took a similar approach to 
establish expression libraries of preimplantation embryos. In the 
late eighties preparing cDNA libraries presumed the availability 
of mRNA in milligram quantities which would imply collecting 
hundreds of thousands if not millions of early mouse embryos, 
a clearly impractical, if not impossible task. In 1987/88 Barbara 
and I spent a sabbatical year at Cold Spring Harbor Laboratory 
and managed to improve cDNA library construction to the 
point that twenty thousand preimplantation stage embryos were 
sufficient. Admittedly, still a high number but possible. We were 
able to construct several cDNA libraries representing full grown 
oocytes and different stages of preimplantation development. 
We used these libraries to analyze the changes in gene expression 
during preimplantation development and to describe mecha-
nisms which regulate gene expression (6). We also for the first 
time described the role of endogenous retroviruses in activating 
expression of specific genes during early development of the 
mouse embryos (7). Finally, we developed the first reliable and 
successful method of nuclear transfer in the mouse zygote (8). 
Using this method, we were able to demonstrate for the first time 
that maternal and paternal genomes in male and female gametes 
are functionally not identical and both have to be present in the 
zygote to insure normal development (9). The process which 
makes genomes functionally different occurs during gametogen-
esis, it is called genomic imprinting and its discovery, in early 
eighties, initiated the conceptualization of epigenetics. 
13. Your contributions to developmental biology were widely 
recognized by your peers and you received some of the 
most prestigious scientific awards. Could you list some of 
your most important awards?
I received the March of Dimes Prize in Developmental Biology 
in 1998 of which I am especially proud as this award specifi-
cally honors contributions to developmental biology. In 2007 
 
Figure 5. Zagreb 2013, Nikola Škreb Symposium: Development and stem cells at the beginning of new millennium. In the Laboratory in the Department of Biology from left 
to right: Davor Ježek, Mladen Belicza, Davor Solter, Pavao Rudan, Takashi Hiiragi, Marko Pećina, Floriana Bulić-Jakuš, Rolf Kemler and Draško Šerman
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Figure 6. Toronto 2018, Davor Solter receives Canada Gairdner International Award. From left to right: Janet Rossant, President Gairdner Foundation, Davor Solter, Lorne 
Tyrrell, Chair of the Board of Directors of the Gairdner Foundation and Her Excellency Marica Matković, The Ambassador of the Republic of Croatia to Canada
Figure 7. Zagreb 2018. Davor Solter lectures at the HAZU. From left to right: Slobodan Vukičević, Pavao Rudan, Davor Solter, Marko Pećina, Ivica Kostović, Ivan Dam-
janov and Vlatko Silobrčić
Essay - Interviews
RAD 547. Medical Sciences 54-55 (2021) : 138-147                   www.rad-med.com 145 June 2021   -   Vol 547 = 54-55
I received Rosenstiel Award for Distinguished Work in Basic 
Medical Research from Brandeis University and in 2018 the 
Canada Gairdner International Award. These were all awarded 
for discovery of imprinting.
14. Over all these years since you left Zagreb, did you keep in 
touch with your Croatian colleagues?
As much as possible. During my time in The Wistar Institute 
several Croatian scientists came to work as postdoctoral fellows 
and visiting scientists. In addition, young scientists came to do 
the laboratory work necessary for their master’s and doctoral 
degree and when they finished, they defended their theses in Za-
greb. Their work resulted in each case in several publications in 
the first-class international journals. Same things happened while 
I was in Max-Plank Institute in Freiburg. I also participated in 
organizing the international scientific meetings in Croatia: in 
Dubrovnik 1986 and in Zagreb 2013 and 2018. In addition, 
during most of my visits to Croatia I gave lectures at the Medical 
School, Institute Ruđer Bošković or HAZU.
In 2018 Barbara Knowles and I spent one month at the Depart-
ment of Biology, of the Medical School in Zagreb as part of 
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine (CERRM) which was established by the Ministry 
of Science, Education and Sport of Croatia and funded by the 
European Union. During that time, we discussed with the mem-
bers of CERRM various scientific projects and made plans with 
them for future collaboration. We devoted most of our time to 
interacting with PhD students in the Department of Biology and 
to helped several of them in designing their research projects. At 
the same time we organized the Second Nikola Škreb Sympo-
sium entitled “New platforms in developmental biology-toward 
the clinical application
15. If you were not a scientist, what would you have done with 
your life?
This is hard question to answer. I cannot think of an alterna-
tive. All the things I might have liked to do require talents that I 
didn’t have . Science sometimes seems nothing but routine, you 
Figure 8. Zagreb 2018. Nikola Škreb Symposium: New platforms in developmental biology-toward the clinical application. Ivan Damjanov, Barbara Knowles and Davor 
Solter sit behind Davor Ježek in the new Čačković Hall auditorium together with the number of students
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go to the lab, you do experiments, they sometimes work and 
sometimes they do not. Data accumulate and sometimes they 
mean something and sometimes, very rarely, they open a new 
vista. The hope is always there that if you are good and lucky you 
will one day know something that, for a moment, nobody else in 
the world knows. When they asked Al Hershey, a Nobel laurate 
in 1969 for his idea of scientific happiness, he answered: “To 
have one experiment that works and keep doing it all the time”. 
This was called “Hershey heaven” and I sometimes think, he may 
have had something.
16. In preparation for this interview I was looking at some of 
your old emails and found one on ligamentum teres capiti 
femoris Bertini. Do you think that today›s medical stu-
dents even know who was Doctor Bertin? 
Maybe they do, let us be optimistic. I always liked eponyms; 
they gave medical terms a personal flavor. However, I am also 
glad that I am not in the medical school today, the number of 
syndromes named after a multitude of discoverers is incred-
ible. I must slightly correct you, Bertin’s ligament is actually the 
ligamentum ileofemorale not the ligamentum teres capitis femoris. 
L. ileofemorale Bertini is the strongest ligament in the human 
body, and I used to tell my students in anatomy classes that, in 
the medieval punishment of quartering, the femur would break 
before the ligament. For some reason I assumed that Bertin 
observed this during the execution of Damiens who attempted to 
kill Louis XV and whose public execution was terribly botched 
(see Foucault’s Surveiller et Punir). I am probably wrong since I 
cannot find any evidence for that, another urban legend. There 
is another interesting thing about the iliofemoral ligament that 
I call “eponym nationalism”. Bertin described it in mid-eighteen 
century, but in the USA the ligament is known as the ligament 
of Bigelow, named after the Civil War surgeon Bigelow who 
described the ligament a hundred years later. You may wonder 
why I know all this trivia but they were part of my first scientific 
work which dealt with the variations in the vascularization of the 
head and neck of the femur and the role of ligaments and joint 
capsule in providing vascularization (10). Like a first child, one’s 
first paper is always special.
17. In another email of yours I see that we were discussing 
Horace and his line Non sum qualis eram. We agreed that 
it is quite factual and refers to both of us. Nothing to add 
or subtract were it not for the fact that it prompted you 
to quote another verse of Horace, used by Ernest Dowson 
as a title of a short poem of his. You wrote that Dowson is 
one of your favorite British poets. I will reprint that poem 
here and ask you to end this interview with two three short 
sentences telling our readers why did you like that poem. 
Vita summa brevis spem nos vetat incohare longam
They are not long, the weeping and the laughter,
Love and desire and hate:
I think they have no portion in us after
We pass the gate
They are not long, the days of wine and roses
Out of a misty dream
Our path emerges for a while, then closes
Within a dream
The movie Gone with the Wind was seen by more than two 
hundred million people and the book was printed in more than 
thirty million copies. Yet I wonder if one in a thousand of these 
viewers and readers knew that the title came from the poem writ-
ten by Ernest Dowson or even knew who Ernest Dowson, poet 
and decadent (as one of his biographers titled him) was. Dowson 
was a “minor” English poet who died young in the first year of 
twentieth century, yet he was admired by and influenced poets 
like T. S. Eliot, Ezra Pound and Rupert Brooke. His command 
of language was exceptional, and nobody found words to convey 
the quiet desperation as Dowson. “Gone with the wind”, “the 
hollow lands”, “the end of all songs”, “the days of wine and roses” 
will remain forever in the treasure chest of the English language 
as will the last line of his last poem: “O pray the earth enfold 
our life-sick hearts and turn them into dust”. Today I prob-
ably appreciate intellectual poets like Eliot more, but I always 
return and reread The Complete Poems of Ernest Dowson, which 
he dedicated, fitting to his troubled life, to his only true and 
fruitless love, the twelve-year-old Adelaide (Missie), daughter 
of the owner of a small Soho restaurant Poland which Dowson 
frequented. Regardless of the esteem and position of Dowson in 
the world literature I certainly agree with the final worlds of his 
biographer, Jad Adams: “Life presented him with suffering, and 
he returned it as beauty”.
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